ArticleBreast cancer (Tokyo, Japan)2022

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.

Mengdi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.